Amgen Quarterly Revenue Rises 6%, Profit Beats Street Estima

The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects a deal to acquire Horizon Therapeutics to close by mid-December.

Related Keywords

California , United States , Peter Griffith , Michael Yee , Deena Beasley , Reuters , Amgen , Us Federal Trade Commission , Trade Commission , Horizon Therapeutics , Chief Financial Officer Peter Griffith , Wall Street , Bill Berkrot , Practice Management , Biomedical Technology , Biotechnology , Biologic Therapy , Thyroid Associated Ophthalmopathy , Thyroid Eye Disease , Hyroid Ophthalmopathy , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Arthritis , Oint Inflammation , Biosimilars , Biosimilar Drugs , Follow On Biologics , , Cancer , Alignant Neoplasia , Arcinoma , Experimental Dr ,